258 related articles for article (PubMed ID: 28127199)
41. The severity of rat liver injury by fructose and high fat depends on the degree of respiratory dysfunction and oxidative stress induced in mitochondria.
García-Berumen CI; Ortiz-Avila O; Vargas-Vargas MA; Del Rosario-Tamayo BA; Guajardo-López C; Saavedra-Molina A; Rodríguez-Orozco AR; Cortés-Rojo C
Lipids Health Dis; 2019 Mar; 18(1):78. PubMed ID: 30927921
[TBL] [Abstract][Full Text] [Related]
42. Therapeutic effect of Pleurotus eryngii cellulose on experimental fatty liver in rats.
Huang JF; Zhan T; Yu XL; He QA; Huang WJ; Lin LZ; Du YT; Pan YT
Genet Mol Res; 2016 Feb; 15(1):15017805. PubMed ID: 26985922
[TBL] [Abstract][Full Text] [Related]
43. Dietary salmon milt extracts attenuate hepatosteatosis and liver dysfunction in diet-induced fatty liver model.
Sakurai T; Hayasaka T; Sekiguchi H; Satoh H; Chen Z; Chiba H; Hui SP
J Sci Food Agric; 2019 Mar; 99(4):1675-1681. PubMed ID: 30198086
[TBL] [Abstract][Full Text] [Related]
44. Preparation and Evaluation of Functional Foods for Prevention of Non-alcoholic Fatty Liver Disease.
A Mohamed D; S Abdelgayed S; A Essa H; S Mohamed R
Pak J Biol Sci; 2018 Jan; 21(9):454-462. PubMed ID: 30724047
[TBL] [Abstract][Full Text] [Related]
45. Abnormal CD44 activation of hepatocytes with nonalcoholic fatty accumulation in rat hepatocarcinogenesis.
Fang M; Yao M; Yang J; Zheng WJ; Wang L; Yao DF
World J Gastrointest Oncol; 2020 Jan; 12(1):66-76. PubMed ID: 31966914
[TBL] [Abstract][Full Text] [Related]
46. Vitamin D attenuates high fat diet-induced hepatic steatosis in rats by modulating lipid metabolism.
Yin Y; Yu Z; Xia M; Luo X; Lu X; Ling W
Eur J Clin Invest; 2012 Nov; 42(11):1189-96. PubMed ID: 22958216
[TBL] [Abstract][Full Text] [Related]
47. [Metformin prevents non-alcoholic fatty liver disease in rats: role of phospholipase A2/lysophosphatidylcholine lipoapoptosis pathway in hepatocytes].
Huang Y; Fu JF; Shi HB; Liu LR
Zhonghua Er Ke Za Zhi; 2011 Feb; 49(2):139-45. PubMed ID: 21426695
[TBL] [Abstract][Full Text] [Related]
48. Electroacupuncture Attenuates Liver Inflammation in Nonalcoholic Fatty Liver Disease Rats.
Ma B; Li P; An H; Song Z
Inflammation; 2020 Dec; 43(6):2372-2378. PubMed ID: 32737656
[TBL] [Abstract][Full Text] [Related]
49. Artemisia capillaris formula inhibits hepatic steatosis via an miR‑122‑induced decrease in fatty acid synthase expression in vivo and in vitro.
Liu L; Zhao J; Li Y; Wan Y; Lin J; Shen A; Xu W; Li H; Zhang Y; Xu J; Peng J; Hong Z
Mol Med Rep; 2016 Jun; 13(6):4751-8. PubMed ID: 27081834
[TBL] [Abstract][Full Text] [Related]
50. [Changes in the intestinal microenvironment during development of alcoholic fatty liver disease and related effects of probiotic therapy].
Zhang B; Lu XL; Song YH; Shi HT; Li J; Geng Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Nov; 20(11):848-52. PubMed ID: 23206305
[TBL] [Abstract][Full Text] [Related]
51. Houttuynia cordata alleviates high-fat diet-induced non-alcoholic fatty liver in experimental rats.
Kang H; Koppula S
Pharm Biol; 2015 Mar; 53(3):414-22. PubMed ID: 25272018
[TBL] [Abstract][Full Text] [Related]
52. [Mitochondrial activities of citrate synthase, carnitine palmitoyltransferase-1 and cytochrome C oxidase are increased during the apoptotic process in hepatocytes of a rat model of acute liver failure].
Chen L; Yang B; Zhou L; Duan Z; Liu W; Ding M
Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):456-61. PubMed ID: 25203711
[TBL] [Abstract][Full Text] [Related]
53. [Efficacy of probiotics on the treatment of non-alcoholic fatty liver disease].
Wang W; Shi LP; Shi L; Xu L
Zhonghua Nei Ke Za Zhi; 2018 Feb; 57(2):101-106. PubMed ID: 29397594
[No Abstract] [Full Text] [Related]
54. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats.
Xu P; Zhang XG; Li YM; Yu CH; Xu L; Xu GY
J Zhejiang Univ Sci B; 2006 Aug; 7(8):627-33. PubMed ID: 16845716
[TBL] [Abstract][Full Text] [Related]
55. Protective effects and mechanisms of total alkaloids of Rubus alceaefolius Poir on non‑alcoholic fatty liver disease in rats.
Zheng H; Zhao J; Zheng Y; Wu J; Liu Y; Peng J; Hong Z
Mol Med Rep; 2014 Oct; 10(4):1758-64. PubMed ID: 25051256
[TBL] [Abstract][Full Text] [Related]
56. Hepatic steatosis during convalescence from influenza B infection in ferrets with postprandial hyperinsulinemia.
Kang ES; Galloway MS; Ellis J; Solomon SS; Bean W; Reger JF; Cook GA; Olson G
J Lab Clin Med; 1990 Sep; 116(3):335-44. PubMed ID: 2205696
[TBL] [Abstract][Full Text] [Related]
57. [Effect of calcium-independent phospholipase A(2) inhibitor in reducing hepatocyte lipoapoptosis and improving insulin resistance].
Shi HB; Fu JF; Huang Y; Liu LR
Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):27-31. PubMed ID: 28297775
[No Abstract] [Full Text] [Related]
58. Promotion of mitochondrial energy metabolism during hepatocyte apoptosis in a rat model of acute liver failure.
Chen LY; Yang B; Zhou L; Ren F; Duan ZP; Ma YJ
Mol Med Rep; 2015 Oct; 12(4):5035-41. PubMed ID: 26135512
[TBL] [Abstract][Full Text] [Related]
59. [Effect of aerobic exercise on AKT/GSK3β mediated hepatocyte apoptosis in nonalcoholic fatty liver disease].
Wang J; Li Y; Jiang C; Li J
Wei Sheng Yan Jiu; 2023 Mar; 52(2):246-252. PubMed ID: 37062687
[TBL] [Abstract][Full Text] [Related]
60. [Protective effect of Saccharomyces boulardii against intestinal mucosal barrier injury in rats with nonalcoholic fatty liver disease].
Liu YT; Li YQ; Wang YZ
Zhonghua Gan Zang Bing Za Zhi; 2016 Dec; 24(12):921-926. PubMed ID: 28073414
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
